EmblemHealth announces layoffs, plans to outsource IT operations

On April 20, EmblemHealth handed out termination notices to 250 employees as the New York-based health insurer attempts to improve its financial standing. The layoffs are primarily in IT and operations departments, with those roles to be outsourced.

The cuts, representing 7.5 percent of the company’s 3,300 employees, are part of an effort to turn around its fortunes after the insurer lost $113 million last year and $485.8 million in 2014.

Emblem has hired Cognizant as an outside provider of IT services to automate processes and improve technology. A number who received layoff notices are being asked to take positions with Cognizant.

While the number of jobs in industry continues to soar, recent reports have pointed to a decline in non-health occupation jobs in healthcare settings.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.